BeOne Medicines (ONC) Construction in Progress (2016 - 2026)

BeOne Medicines (ONC) has reported Construction in Progress for 10 consecutive years, with $137.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Construction in Progress fell 76.7% year-over-year to $137.4 million; the TTM figure through Mar 2026 stood at $137.4 million (down 76.7% YoY), while the FY2025 annual figure was $127.2 million, down 80.56% from the prior year.
• Construction in Progress climbed to $137.4 million in Q1 2026 per ONC's latest filing, from $127.2 million in the prior quarter.
• Across five years, Construction in Progress topped out at $863.4 million in Q2 2024 and bottomed at $127.2 million in Q4 2025.
• Historically, Construction in Progress has averaged $447.9 million across 5 years, with a median of $430.6 million in 2023.
• Annual changes were most pronounced in 2023 — Construction in Progress jumped 184.02% — and 2025, when it tumbled 80.56%.
• BeOne Medicines' Construction in Progress stood at $293.6 million in 2022, then surged by 152.23% to $740.6 million in 2023, then retreated by 11.69% to $654.0 million in 2024, then sank by 80.56% to $127.2 million in 2025, then increased by 8.09% to $137.4 million in 2026.
• Business Quant data shows ONC's Construction in Progress at $137.4 million in Q1 2026, $127.2 million in Q4 2025, and $129.1 million in Q3 2025.